Merit Medical Systems, Inc. (NASDAQ:MMSI)‘s stock had its “buy” rating restated by equities researchers at Canaccord Genuity in a report released on Wednesday. They presently have a $45.00 price target on the medical instruments supplier’s stock. Canaccord Genuity’s price objective indicates a potential upside of 8.70% from the stock’s previous close.

A number of other equities analysts have also commented on MMSI. SunTrust Banks, Inc. initiated coverage on Merit Medical Systems in a report on Tuesday, June 20th. They issued a “buy” rating and a $43.00 price target for the company. Zacks Investment Research raised Merit Medical Systems from a “hold” rating to a “buy” rating and set a $41.00 price target for the company in a report on Thursday, June 22nd. Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $39.00 price target on shares of Merit Medical Systems in a report on Monday, June 26th. BidaskClub raised Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 27th. Finally, Sidoti reaffirmed a “buy” rating and issued a $46.00 price target (up from $41.00) on shares of Merit Medical Systems in a report on Wednesday, June 28th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. Merit Medical Systems currently has an average rating of “Buy” and a consensus price target of $41.25.

Shares of Merit Medical Systems (NASDAQ MMSI) traded up 2.35% during trading on Wednesday, reaching $41.40. The company’s stock had a trading volume of 280,313 shares. Merit Medical Systems has a 52-week low of $20.70 and a 52-week high of $42.60. The stock has a 50-day moving average of $40.69 and a 200-day moving average of $34.92. The stock has a market cap of $2.08 billion, a P/E ratio of 58.97 and a beta of 1.25.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 EPS for the quarter, topping the Zacks’ consensus estimate of $0.29 by $0.07. Merit Medical Systems had a return on equity of 9.78% and a net margin of 4.87%. The firm had revenue of $186.50 million during the quarter, compared to analyst estimates of $181.46 million. During the same period last year, the company earned $0.26 earnings per share. The business’s revenue for the quarter was up 23.4% on a year-over-year basis. Analysts predict that Merit Medical Systems will post $1.26 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Merit Medical Systems’ (MMSI) Buy Rating Reiterated at Canaccord Genuity” was posted by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/10/merit-medical-systems-mmsi-buy-rating-reiterated-at-canaccord-genuity.html.

In other Merit Medical Systems news, insider Richard W. Edelman sold 20,000 shares of the firm’s stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $37.62, for a total transaction of $752,400.00. Following the sale, the insider now owns 35,000 shares in the company, valued at $1,316,700. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director F. Ann Millner sold 3,106 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $41.01, for a total value of $127,377.06. Following the sale, the director now owns 6,750 shares in the company, valued at approximately $276,817.50. The disclosure for this sale can be found here. Insiders sold 98,250 shares of company stock worth $3,932,799 in the last quarter. 5.00% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MMSI. BlackRock Inc. raised its position in Merit Medical Systems by 7,837.9% during the first quarter. BlackRock Inc. now owns 6,789,527 shares of the medical instruments supplier’s stock valued at $196,218,000 after purchasing an additional 6,703,994 shares in the last quarter. Janus Henderson Group PLC raised its position in Merit Medical Systems by 922.3% during the second quarter. Janus Henderson Group PLC now owns 1,533,513 shares of the medical instruments supplier’s stock valued at $58,504,000 after purchasing an additional 1,383,513 shares in the last quarter. Private Advisor Group LLC purchased a new stake in Merit Medical Systems during the first quarter valued at about $444,000. Vanguard Group Inc. raised its position in Merit Medical Systems by 16.1% during the first quarter. Vanguard Group Inc. now owns 4,186,883 shares of the medical instruments supplier’s stock valued at $121,001,000 after purchasing an additional 580,871 shares in the last quarter. Finally, Frontier Capital Management Co. LLC raised its position in Merit Medical Systems by 24.8% during the second quarter. Frontier Capital Management Co. LLC now owns 2,737,303 shares of the medical instruments supplier’s stock valued at $104,428,000 after purchasing an additional 543,580 shares in the last quarter. Institutional investors and hedge funds own 89.11% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.